Effectiveness and safety of secukinumab in ankylosing spondylitis: real-life data from Midlands Ankylosing Spondylitis Collaboration (MASC)
(2022)
Journal Article
Ajibade, A., Pandian, H., Jain, N., Gupta, L., Laxminarayan, R., Moorthy, A., Amarasena, R., Cox, N., Sapkota, H., Kakade, G., Elamanchi, S., Prabu, A., Al-Samaraaie, E., & Barkham, N. (2022). Effectiveness and safety of secukinumab in ankylosing spondylitis: real-life data from Midlands Ankylosing Spondylitis Collaboration (MASC). Rheumatology Advances in Practice, 7(1), https://doi.org/10.1093/rap/rkad029
Outputs (2)
The impact of the COVID-19 pandemic and stringent social distancing measures on health-related quality of life and COVID-19 infection rates in patients with rheumatic disease: a longitudinal analysis through the pandemic (2022)
Journal Article
Cox, N., R Raizada, S., Barkham, N., Venkatachalam, S., Sheeran, T. P., Adizie, T., Sapkota, H., C Scott, I., Muller, S., & Bateman, J. (2022). The impact of the COVID-19 pandemic and stringent social distancing measures on health-related quality of life and COVID-19 infection rates in patients with rheumatic disease: a longitudinal analysis through the pandemic. Rheumatology Advances in Practice, 7(1), Article rkad009. https://doi.org/10.1093/rap/rkad009Objective The aim was to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic and stringent social isolation measures on patients with rheumatic disease (RD) from the beginning of the pandemic (April 2020). Methods In this UK-based... Read More about The impact of the COVID-19 pandemic and stringent social distancing measures on health-related quality of life and COVID-19 infection rates in patients with rheumatic disease: a longitudinal analysis through the pandemic.